Noninvasive mapping to guide a heart resynchronization device
Part of Heart & circulation clinical trials.
This trial tests a noninvasive way to map your heart’s wiring and veins to help guide placement of a heart resynchronization therapy (CRT) device. If you have certain abnormal heart rhythm and weak heart pumping, it may help doctors place the therapy more accurately and safely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 or older and can sign consent
- You have CRT-eligible heart failure with left bundle branch block (LBBB) and a wide QRS (130 ms or more)
- Your heart rhythm is sinus rhythm (not ongoing atrial fibrillation)
- Your left heart pumping is reduced (ejection fraction 35% or less) and you have symptoms despite care (NYHA II or higher)
- You’ve been on stable heart failure medicines for at least 6 months and had no major heart procedure in the last 6 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a different pacing approach called left bundle branch pacing can improve outcomes and heart structure changes in people who did not improve with standard biventricular CRT. It may help some patients with ongoing heart failure symptoms and weak heart pumping.
This trial tests a special pacing method for people with heart failure. It aims to improve the heart's pumping by using a more natural pacing approach.
This trial tests a pacing approach designed to improve how the heart beats in some people with heart failure and a specific heart rhythm pattern on ECG. If you already need a device (CRT-D) based on your results, the study may help see whether this pacing correction improves outcomes.
This trial tests a new way to use an ECG (electrical heart recording) to predict who will benefit from a special pacemaker called cardiac resynchronization therapy (CRT). It is for people with heart failure and a specific heart rhythm problem.
This trial tests a heart device (CRT) that coordinates your heart's contractions, combined with a new electrical mapping technique to place leads more precisely. It's designed for people with weak heart function and abnormal electrical patterns who haven't improved enough with medications alone.
This trial tests whether a special noninvasive heart “mapping” test done on the body can help improve outcomes for people who need a CRT device. It studies whether mapping before implantation can better guide or predict how well the CRT will work.
Hear when a new Cardiac Resynchronization Therapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.